Archive Prostate. Observational Study of Patients Who Underwent Radical Prostatectomy Surgery

Sponsor
IRCCS San Raffaele (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT06154499
Collaborator
(none)
1,784
1
250.2
7.1

Study Details

Study Description

Brief Summary

This is a single-center, observational, prospective study on quality of life and disease status of patients who underwent radical prostatectomy. Data related to clinical conditions (oncological, psychological, sexual and quality of life) of these patients are collected in a database.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Radical prostatectomy

Detailed Description

A database was created with the intention of collecting data related to patients with diagnosis of prostate cancer who underwent radical prostatectomy.

Anamnesis, surgery, histological report and hospitalization data are collected for patients who underwent radical prostatectomy.

Each patient will be followed for 10 years from the date of radical prostatectomy surgery.

Each patient will receive a questionnaire before radical prostatectomy in order to evaluate the quality of life (urinary continence, erectile function and psycho-physical wellbeing). A follow up questionnaire will be collected after surgery in order to analyze the predictive factors of the disease, clinical progression and to obtain health benefits for the patients involved and for future patients with the same tipe of cancer, improving the scientific knowledge of the pathology and implementing new strategies for diagnosis and therapy and evaluating the epidemiologic changes of prostate cancer. Tha data collected will be handles following the most strict Good Clinical Practice (GCPs) and privacy norms.

Study Design

Study Type:
Observational
Actual Enrollment :
1784 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Archive Prostate. Observational Study of Patients Who Underwent Radical Prostatectomy Surgery. Long-term Evaluation of the Course of Prostate Cancer Associated With Quality of Life, Post-surgery Treatments and Occurrence of Any Disease Recurrence
Actual Study Start Date :
Apr 8, 2004
Anticipated Primary Completion Date :
Feb 13, 2025
Anticipated Study Completion Date :
Feb 13, 2025

Arms and Interventions

Arm Intervention/Treatment
Patients referred to the Urology Department who need to undergo radical prostatectomy surgery

Procedure: Radical prostatectomy
Radical Prostatectomy: surgery to remove the prostate gland and seminal vesicles (and sometimes nearby lymph nodes) after a prostate cancer diagnosis

Outcome Measures

Primary Outcome Measures

  1. Early Urinary continence recovery [6 months after the intervention/procedure/surgery]

    Continence recovery evaluated with the International Consultation on Incontinence questionnaire - short form (ICIQ-SF), International Prostatic Symptoms Score (IPSS) questionnaires

  2. Early Erectile function recovery [6 months after the intervention/procedure/surgery]

    Erectile function recovery evaluated with the International Index of Erectile Function (IIEF) questionnaire

  3. Prostate-specific antigen (PSA) persistence or biochemical recurrence [6 months and every year after the intervention/procedure/surgery up to 10 years]

    Serum PSA levels, conventional imaging

Secondary Outcome Measures

  1. Urinary continence recovery [every year after the intervention/procedure/surgery up to 10 years]

    Continence recovery evaluated with the International Consultation on Incontinence

  2. Erectile function recovery [every year after the intervention/procedure/surgery up to 10 years]

    Erectile function recovery evaluated with the International Index of Erectile Function (IIEF)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with prostate cancer who underwent radical prostatectomy;

  • Adult patients > 18 years

  • Ability to read and sign the informed consent

Exclusion Criteria:
  • Patients < 18 years

  • mental or physical disability that may prevent the patient from satisfying the requirements of the protocol

  • Inability to read and sign the informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Francesco Montorsi Milan Italy

Sponsors and Collaborators

  • IRCCS San Raffaele

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Francesco Montorsi, Professor, IRCCS San Raffaele
ClinicalTrials.gov Identifier:
NCT06154499
Other Study ID Numbers:
  • 2004- Prostata
First Posted:
Dec 4, 2023
Last Update Posted:
Dec 4, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 4, 2023